U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination
    • Showing Current items.

    Havcr1 hepatitis A virus cellular receptor 1 [ Mus musculus (house mouse) ]

    Gene ID: 171283, updated on 18-Sep-2024

    GeneRIFs: Gene References Into Functions

    GeneRIFPubMed TitleDate
    A renal YY1-KIM1-DR5 axis regulates the progression of acute kidney injury.

    A renal YY1-KIM1-DR5 axis regulates the progression of acute kidney injury.
    Yang C, Xu H, Yang D, Xie Y, Xiong M, Fan Y, Liu X, Zhang Y, Xiao Y, Chen Y, Zhou Y, Song L, Wang C, Peng A, Petersen RB, Chen H, Huang K, Zheng L., Free PMC Article

    07/24/2023
    KIM-1 augments hypoxia-induced tubulointerstitial inflammation through uptake of small extracellular vesicles by tubular epithelial cells.

    KIM-1 augments hypoxia-induced tubulointerstitial inflammation through uptake of small extracellular vesicles by tubular epithelial cells.
    Chen J, Tang TT, Cao JY, Li ZL, Zhong X, Wen Y, Shen AR, Liu BC, Lv LL., Free PMC Article

    05/10/2023
    T-Cell Immunoglobulin and Mucin Domain 1 (TIM-1) Is a Functional Entry Factor for Tick-Borne Encephalitis Virus.

    T-Cell Immunoglobulin and Mucin Domain 1 (TIM-1) Is a Functional Entry Factor for Tick-Borne Encephalitis Virus.
    Zhang X, Liang C, Wang H, Guo Z, Rong H, Pan J, Li W, Pei R, Chen X, Zhang Z, Zhang XE, Cui Z., Free PMC Article

    03/2/2023
    Tim-1 mucin domain-mutant mice display exacerbated atherosclerosis.

    Tim-1 mucin domain-mutant mice display exacerbated atherosclerosis.
    Douna H, Smit V, van Puijvelde GHM, Kiss MG, Binder CJ, Bot L, Kuchroo VK, Lichtman AH, Kuiper J, Foks AC.

    07/2/2022
    Acute Kidney Injury Associates with Long-Term Increases in Plasma TNFR1, TNFR2, and KIM-1: Findings from the CRIC Study.

    Acute Kidney Injury Associates with Long-Term Increases in Plasma TNFR1, TNFR2, and KIM-1: Findings from the CRIC Study.
    McCoy IE, Hsu JY, Bonventre JV, Parikh CR, Go AS, Liu KD, Ricardo AC, Srivastava A, Cohen DL, He J, Chen J, Rao PS, Hsu CY, Chronic Renal Insufficiency Cohort (CRIC) Study Investigators., Free PMC Article

    06/11/2022
    Kidney injury molecule-1 inhibits metastasis of renal cell carcinoma.

    Kidney injury molecule-1 inhibits metastasis of renal cell carcinoma.
    Lee JC, Yotis DM, Lee JY, Sarabusky MA, Shrum B, Champagne A, Ismail OZ, Tutunea-Fatan E, Leong HS, Gunaratnam L., Free PMC Article

    11/22/2021
    Rutin coated gold nanoparticles prevent rhabdomyolysis-induced kidney injury via down-regulation of NF-kB, iNOS, IL-6 and up-regulation of HO-1 and Kim-1 genes in mice.

    Rutin coated gold nanoparticles prevent rhabdomyolysis-induced kidney injury via down-regulation of NF-kB, iNOS, IL-6 and up-regulation of HO-1 and Kim-1 genes in mice.
    Saifulah N, Siddiqui RA, Ismail MO, Memon Z, Aslam Z, Shah MR.

    10/23/2021
    KIM-1-mediated anti-inflammatory activity is preserved by MUC1 induction in the proximal tubule during ischemia-reperfusion injury.

    KIM-1-mediated anti-inflammatory activity is preserved by MUC1 induction in the proximal tubule during ischemia-reperfusion injury.
    Al-Bataineh MM, Kinlough CL, Mi Z, Jackson EK, Mutchler SM, Emlet DR, Kellum JA, Hughey RP., Free PMC Article

    09/25/2021
    Mapping and functional characterization of murine kidney injury molecule-1 proteolytic cleavage site.

    Mapping and functional characterization of murine kidney injury molecule-1 proteolytic cleavage site.
    Sriranganathan S, Tutunea-Fatan E, Abbasi A, Gunaratnam L.

    07/17/2021
    These studies provide evidence that at late times during Ebola virus glycoprotein/recombinant vesiculovirus infection, TIM-1 increased virus load and associated mortality, consistent with an important role of this receptor in virus entry.

    TIM-1 serves as a receptor for Ebola virus in vivo, enhancing viremia and pathogenesis.
    Brunton B, Rogers K, Phillips EK, Brouillette RB, Bouls R, Butler NS, Maury W., Free PMC Article

    11/30/2019
    Our findings suggest a role for UMOD-dependent inhibition of KIM-1 expression and its apoptotic cell scavenging responses during chronic obstruction-associated tubular injury

    Uromodulin deficiency alters tubular injury and interstitial inflammation but not fibrosis in experimental obstructive nephropathy.
    Maydan O, McDade PG, Liu Y, Wu XR, Matsell DG, Eddy AA., Free PMC Article

    03/23/2019
    findings show that TIM1 is not required for hepatitis A virus (HAV) replication and pathogenesis in permissive strains of mice, although it may facilitate early stages of infection by binding phosphatidylserine on the quasi-enveloped HAV surface

    TIM1 (HAVCR1) Is Not Essential for Cellular Entry of Either Quasi-enveloped or Naked Hepatitis A Virions.
    Das A, Hirai-Yuki A, González-López O, Rhein B, Moller-Tank S, Brouillette R, Hensley L, Misumi I, Lovell W, Cullen JM, Whitmire JK, Maury W, Lemon SM., Free PMC Article

    06/30/2018
    the interaction of TIM4TIM1 was found to promote Th2cell proliferation through enhancing SIRT1 expression in mice with nasal allergic rhinitis.

    TIM4-TIM1 interaction modulates Th2 pattern inflammation through enhancing SIRT1 expression.
    Hu T, Fan X, Ma L, Liu J, Chang Y, Yang P, Qiu S, Chen T, Yang L, Liu Z., Free PMC Article

    06/2/2018
    findings provide evidence for the role of Tim-1 in the induction of a cytokine storm phenomenon and the pathogenesis of Ebola virus disease

    Ebola Virus Binding to Tim-1 on T Lymphocytes Induces a Cytokine Storm.
    Younan P, Iampietro M, Nishida A, Ramanathan P, Santos RI, Dutta M, Lubaki NM, Koup RA, Katze MG, Bukreyev A., Free PMC Article

    05/19/2018
    Cisplatin enhances kidney injury molecule-1 (Kim-1) gene expression in kidney S3 cells.

    A kidney injury molecule-1 (Kim-1) gene reporter in a mouse artificial chromosome: the responsiveness to cisplatin toxicity in immortalized mouse kidney S3 cells.
    Kokura K, Kuromi Y, Endo T, Anzai N, Kazuki Y, Oshimura M, Ohbayashi T., Free PMC Article

    02/3/2018
    By preventing ERK1/2 phosphorylation following renal injury, STAT3 phosphorylation is decreased, leading to less phosphorylated STAT3 within the nucleus, and subsequently less KIM-1 mRNA increases post injury

    Extracellular Signal-Regulated Kinase 1/2 Regulates Mouse Kidney Injury Molecule-1 Expression Physiologically and Following Ischemic and Septic Renal Injury.
    Collier JB, Schnellmann RG., Free PMC Article

    12/2/2017
    Study used a previously described highly mobile membrane mimetic membrane in combination with a conventional lipid bilayer model to generate a membrane-bound configuration of Tim1 in silico, identified two possible states for a membrane-bound form of Tim1.

    Coupling X-Ray Reflectivity and In Silico Binding to Yield Dynamics of Membrane Recognition by Tim1.
    Tietjen GT, Baylon JL, Kerr D, Gong Z, Henderson JM, Heffern CTR, Meron M, Lin B, Schlossman ML, Adams EJ, Tajkhorshid E, Lee KYC., Free PMC Article

    12/2/2017
    Our data reveal a previously unknown role for Galpha12 in regulating efferocytosis and that renal tubular epithelial cells require KIM-1 to mediate this process.

    G protein α(12) (Gα(12)) is a negative regulator of kidney injury molecule-1-mediated efferocytosis.
    Ismail OZ, Zhang X, Bonventre JV, Gunaratnam L., Free PMC Article

    07/8/2017
    Urinary L-FABP, NGAL, Kim-1 and albumin levels increased during the acute phase of kidney injury and were significantly correlated with the degree of tubulointerstitial fibrosis during the chronic phase. These markers could detect higher risk of progression to CKD.

    Increase in urinary markers during the acute phase reflects the degree of chronic tubulointerstitial injury after ischemia-reperfusion renal injury.
    Hisamichi M, Kamijo-Ikemori A, Sugaya T, Ichikawa D, Hoshino S, Hirata K, Kimura K, Shibagaki Y.

    02/4/2017
    Blockade of Tim-1 changes Th1/Th2 balance and reduces circulating regulatory T cells to enhance atherosclerosis in LDL receptor knockout mice.

    Blockade of Tim-1 and Tim-4 Enhances Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient Mice.
    Foks AC, Engelbertsen D, Kuperwaser F, Alberts-Grill N, Gonen A, Witztum JL, Lederer J, Jarolim P, DeKruyff RH, Freeman GJ, Lichtman AH., Free PMC Article

    07/16/2016
    Our results suggest that KIM-1 is an endogenous protective mechanism against renal ischemia-reperfusion injury

    Kidney injury molecule-1 protects against Gα12 activation and tissue damage in renal ischemia-reperfusion injury.
    Ismail OZ, Zhang X, Wei J, Haig A, Denker BM, Suri RS, Sener A, Gunaratnam L., Free PMC Article

    01/23/2016
    data suggest that TIM-1 signaling plays a direct role in Breg maintenance and induction both under physiological conditions (in response to ACs) and in response to therapy through TIM-1 ligation

    TIM-1 signaling is required for maintenance and induction of regulatory B cells.
    Yeung MY, Ding Q, Brooks CR, Xiao S, Workman CJ, Vignali DA, Ueno T, Padera RF, Kuchroo VK, Najafian N, Rothstein DM., Free PMC Article

    12/19/2015
    Deletion of the mucin domain impaired KIM-1-mediated phagocytic function, resulting in increased proinflammatory cytokine production, decreased antiinflammatory growth factor secretion by proximal epithelial cells, and an increase in tissue macrophages.

    KIM-1-mediated phagocytosis reduces acute injury to the kidney.
    Yang L, Brooks CR, Xiao S, Sabbisetti V, Yeung MY, Hsiao LL, Ichimura T, Kuchroo V, Bonventre JV., Free PMC Article

    07/4/2015
    Tim-1 is critical for maintaining self-tolerance by regulating IL-10 production in Bregs

    Tim-1 is essential for induction and maintenance of IL-10 in regulatory B cells and their regulation of tissue inflammation.
    Xiao S, Brooks CR, Sobel RA, Kuchroo VK., Free PMC Article

    04/25/2015
    blood biomarker that specifically reflects acute and chronic kidney injury

    Blood kidney injury molecule-1 is a biomarker of acute and chronic kidney injury and predicts progression to ESRD in type I diabetes.
    Sabbisetti VS, Waikar SS, Antoine DJ, Smiles A, Wang C, Ravisankar A, Ito K, Sharma S, Ramadesikan S, Lee M, Briskin R, De Jager PL, Ngo TT, Radlinski M, Dear JW, Park KB, Betensky R, Krolewski AS, Bonventre JV., Free PMC Article

    12/20/2014
    firstprevious page of 3 nextlast